Medicare Insolvency Date Pushed Up, But Impact Seen as Minimal

Daulerio, A.J.
April 2003
Bond Buyer;4/8/2003, Vol. 344 Issue 31610, p4
Trade Publication
The senior-citizen population is one of the fastest growing demographic groups in the U.S. The demand for health care services from this group will be of major concern to both the government and health care systems. However, the projection from Medicare trustees in March 2003 that the program that provides health insurance to U.S. seniors will be insolvent in 2026 instead of their previous date of 2030 will not have a significant short-term credit implications for health care, according to comments from rating agencies and industry experts. Although its impact may be minimal so far, the revision of the insolvency date by the Medicare trustees could increase budgetary pressures on Medicare spending for many hospitals.


Related Articles

  • What's new for the old.  // Crain's New York Business;10/24/2005, Vol. 21 Issue 43, p29 

    This article reports that overall health care spending by seniors in the United States is projected to increase by 75% between 1992 and 2010, according to a new study. Nearly 13% of New York's residents are over the age of 65 years, and that number is expected to rapidly multiply as the first...

  • Adults Satisfied with Medicare Part D.  // Journal of Gerontological Nursing;Feb2009, Vol. 35 Issue 2, p8 

    The article reports o the results of a national telephone survey of 1,000 U.S. adults age 65 and older which was conducted by RetireSafe. The survey found that 92% of adults enrolled in the Medicare Part D prescription drug benefit plan in 2008 were satisfied with their coverage. The survey also...

  • Rules issued for Medicare prescription drug benefit.  // Nation's Health;Mar2005, Vol. 35 Issue 2, p5 

    This article discusses the release of final regulations for the Medicare prescription drug benefit in the U.S. in late January 2005. Designed to improve access to drugs at lower cost for the nation's seniors, the Medicare drug benefit is a key element of the Medicare Modernization Act passed and...

  • Out-of-Pocket Prescription Costs a Continuing Burden Under Medicare Part D.  // American Family Physician;2/1/2006, Vol. 73 Issue 3, p402 

    Discusses the issue concerning out-of-pocket prescription costs under Medicare Part D. Percentage of beneficiaries who are expected to increase their out-of-pocket costs under Medicare Part D; Expected increase in nonmedication costs; Need for policymakers to address how to control the rise in...

  • Large annual increase in health share of GDP expected in US.  // PharmacoEconomics & Outcomes News;3/7/2009, Issue 573, p10 

    The article focuses on a report from economists from the Medicare and Medicaid Services in Baltimore, Maryland which states that the recession has wide implications for healthcare spending in the U.S. Their report explains that healthcare spending is expected to be 6.2 percent yearly from 2008...

  • What you need to know about Medicare Part D.  // Consumer Reports;Feb2006, Vol. 71 Issue 2, p34 

    The article offers information about Medicare's prescription drug benefit program in the United States. Information is provided for deciding whether or not to buy a drug plan. Older people who want to cut insurance costs can join a Medicare health maintenance organization or preferred provider...

  • The Medicare drug plan: How to help your parents. Quinn, Jane Bryant; Greco, Patricia // Good Housekeeping;Apr2006, Vol. 242 Issue 4, p79 

    The article provides information on the Medicare Part D prescription benefit program for older people in the U.S. A standard plan for 2006 costs $250 in covered drug expenses. Compared to a regular Medicare, prescription drug plans are offered through private insurance companies. Comparison...

  • Medicare Plans' Administrative Costs Continue Moderating Trend.  // Biomedical Market Newsletter;11/7/2011, Vol. 21, p430 

    The article reports on the 0.9-percent growth per member of the administrative expenses of Medicare plans in 2010. It notes that the rate is higher compared in 2009, which suffered a 4.1-percent decline in 2009. It adds that the decline is driven by the marketing trend and the elimination of the...

  • Low Levels of Awareness of Pharmaceutical Cost-Assistance Programs Among Inner-City Seniors. Federman, Alex D.; Safran, Dana Gelb; Keyhani, Salomeh; Siu, Albert L.; Halm, Ethan A. // JAMA: Journal of the American Medical Association;9/24/2008, Vol. 300 Issue 12, p1412 

    The article discusses drug costs for senior citizens in the U.S. The authors report that, despite the roles played by Medicare Part D, the Medicare low-income subsidy program (Extra Help), and state-sponsored pharmaceutical programs in assisting with the high drug costs, the programs are...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics